D I G I T A L D I A G N O S T I C S
HealthEdge and Zelis announce strategic partnership to streamline healthcare payments
HealthEdge and Zelis have announced a strategic partnership aimed at modernising the healthcare payment landscape .
The collaboration will leverage HealthEdge ’ s next generation core administrative processing system ( CAPS ) and the Zelis Advanced Payments Platform ( ZAPP ) to enhance the efficiency , accuracy and transparency of healthcare payments .
“ Health Plans have many challenges , including expanding to new markets , adopting value-based care payment arrangements , meeting evolving industry regulations and more ,” said Alan Stein , Chief Product and Strategy Officer , HealthEdge .
“ Plans must maximise member cost savings and streamline the payment process to make it more efficient .”
Building upon an existing adjudication integration partnership , the collaboration aims to reduce friction and enhance the member and provider experience .
The integration of HealthEdge ’ s modern cloud-based platform with Zelis ’ single-hub payments and data solution streamlines workflows , minimises custom code and supports a seamless payment process .
This ensures seamless payment interactions between health plans , providers and members , improving satisfaction and reducing friction .
“ ZAPP is the industry ’ s first integrated payments and communications platform delivering digital conveniences and experiences that benefit payers , providers and members ,” added Yusuf Qasim , President , Payments Opitimisation , Zelis .
“ In partnership with HealthEdge , we can help resource-constrained health plans modernise their payments experience and seamlessly scale into new markets and reach providers and members without further implementation .”
RNA therapeutic market as the industry faces demand for RNA production that cannot be met by chemical synthesis alone . It builds upon recent important progress shared by EnPlusOne , including the breakthrough synthesis of the antisense strand of the commercially approved siRNA drug , Leqvio ( inclisiran ), a treatment for hypercholesteremia ( high cholesterol ) licensed from Alnylam Pharmaceuticals , Inc . by Novartis , that currently addresses a multi-million patient population .
EnPlusOne was launched by the Wyss Institute in 2022 to commercialise its
With the integration of HealthEdge and Zelis systems , health plans will benefit from more efficient and less complex data exchange , reducing administrative burden .
The out-of-the-box integration – enabled by advanced technologies and industry expertise – paves the way for an automated payment process that can deliver more value to health plans , providers and members .
enzymatic RNA oligonucleotide synthesis technology developed in the laboratory of Co-founder George Church , PhD .
Seed financing was led by Northpond Ventures , with participation from Breakout Ventures , Coatue and individual investors . �
www . intelligenthealth . tech 65